SMTL ID : 8cz8.2 (1 other biounit)

Novel Anti-Mesothelin Antibodies Enable Crystallography of the Intact Mesothelin Ectodo- main and Engineering of Potent, T cell-engaging Bispecific Therapeutics

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

hetero-1-1-1-mer

Ligands

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 3 residues within 4Å: Chain B: S.61, R.63, Q.81 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:S.61, B:Q.81, B:Q.81 Salt bridges: B:R.63 SO4.2: 4 residues within 4Å: Chain A: K.128 Chain C: L.150, T.151, Y.155 3 PLIP interactions: 1 interactions with chain A, 2 interactions with chain C Salt bridges: A:K.128 Hydrogen bonds: C:T.151, C:T.151

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lin, I. et al., Novel mesothelin antibodies enable crystallography of the intact mesothelin ectodomain and engineering of potent, T cell-engaging bispecific therapeutics. Front. Drug Discov. (2023)

Release Date

2023-06-07

Peptides

Mesothelin, cleaved form: A
scFv Anetumab: B
scFv of A12 anti-mesothelin antibody: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
M

B
A

C
B

Mesothelin, cleaved form

scFv Anetumab

scFv of A12 anti-mesothelin antibody

Related Entries With Identical Sequence